SGX PHARMACEUTICALS
DEAD

Serial Number

78702351

Owner

SGX PHARMACEUTICALS, INC.

Attorney

Kent M. Walker, Esq.

First Use Date

Aug 30, 2005

Filing Date

Aug 29, 2005

Add to watchlist:

No watchlists yet
View on USPTO

SGX PHARMACEUTICALS Trademark

Serial Number: 78702351 • Registration: 3529111

SGX PHARMACEUTICALS is a trademark filed by SGX PHARMACEUTICALS, INC. on August 29, 2005. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SGX PHARMACEUTICALS, INC. (4 trademarks)

10505 ROSELLE STREET
SAN DIEGO, CA 92121

Entity Type: 03

Structural Genomix, Inc. (4 trademarks)

10505 Roselle
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

August 29, 2005

Registration Date

November 4, 2008

First Use Anywhere

August 30, 2005

First Use in Commerce

August 30, 2005

Published for Opposition

January 2, 2007

Cancellation Date

June 5, 2015

Goods & Services

Computer software for use in drug discovery, pharmaceutical research, or biotechnology research; computer software for chemical analysis and identification, design, or modification of chemical entities; computer software for protein structure or protein crystal analysis; computer software for coordinated chemical and protein structure analysis

Pharmaceuticals and pharmaceutical preparations used for kinase inhibition or for treating cancer, viral infections, tumors, hematological or oncological disorders, inflammatory disorders, infectious diseases, immune system disorders, allergic disorders, cardiovascular disorders, pulmonary disorders, gastrointestinal disorders, hepatic and biliary disorders, nutritional and metabolic disorders, endocrine disorders, gynecological disorders, obstetric conditions, musculoskeletal and connective tissue disorders, neurological disorders, psychiatric disorders, genitourinary disorders, pediatric conditions, otolaryngological disorders, ophthalmologic disorders, dermatological disorders, dental and oral disorders, disorders due to physical agents, poisoning, venomous bites or stings, or human disease; chemicals and chemical formulations for medical use or for kinase inhibition or for treating human disease, hematological or oncological disorders, or inflammatory disorders

Chemicals used for drug discovery, drug design, drug development, structural biology, scientific analysis, kinase inhibition, or biotechnology; chemical compounds and chemical formulations used for drug discovery, drug design, drug development, structural biology, scientific analysis, kinase inhibition, or biotechnology; proteins and protein crystals used for crystallization, drug discovery, drug design, drug development, structural biology, structure determination, scientific analysis or research, or biotechnology; chemicals and chemical preparations used for design, manufacture or development of pharmaceuticals, or pharmaceutical preparations

Pharmaceutical research, drug discovery, and drug development services; chemical structure analysis or design; identification, design, or modification of chemical entities; protein structure, protein crystal, or protein co-crystal analysis; biotechnology research; bioinformatics research; scientific analysis

Filing History

CANCELLED SEC. 8 (6-YR)
Jun 5, 2015 C8..
REGISTERED-PRINCIPAL REGISTER
Nov 4, 2008 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Sep 30, 2008 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 30, 2008 CNPR
AMENDMENT FROM APPLICANT ENTERED
Sep 15, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2008 CRFA
ASSIGNED TO LIE
Sep 15, 2008 ALIE
PAPER RECEIVED
Sep 11, 2008 MAIL
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 10, 2008 GNFN
FINAL REFUSAL E-MAILED
Mar 10, 2008 GNFR
SU - FINAL REFUSAL - WRITTEN
Mar 10, 2008 CNFR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 25, 2008 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 25, 2008 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 17, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 17, 2008 CRFA
ASSIGNED TO LIE
Feb 17, 2008 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 16, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 26, 2007 GNRN
NON-FINAL ACTION E-MAILED
Oct 26, 2007 GNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 26, 2007 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Oct 4, 2007 SUPC
SOU EXTENSION 1 GRANTED
Oct 4, 2007 EX1G
USE AMENDMENT FILED
Sep 24, 2007 IUAF
SOU EXTENSION 1 FILED
Sep 24, 2007 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 24, 2007 EEXT
TEAS STATEMENT OF USE RECEIVED
Sep 24, 2007 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
Mar 27, 2007 NOAM
PUBLISHED FOR OPPOSITION
Jan 2, 2007 PUBO
NOTICE OF PUBLICATION
Dec 13, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 13, 2006 PREV
ASSIGNED TO LIE
Nov 9, 2006 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 3, 2006 CNSA
EXAMINERS AMENDMENT MAILED
Nov 3, 2006 CNEA
EXAMINER'S AMENDMENT ENTERED
Nov 2, 2006 XAEC
EXAMINERS AMENDMENT -WRITTEN
Nov 2, 2006 CNEA
ASSIGNED TO EXAMINER
Oct 4, 2006 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2006 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2006 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2006 TROA
NON-FINAL ACTION MAILED
Mar 21, 2006 CNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2006 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2006 DOCK
NEW APPLICATION ENTERED
Sep 6, 2005 NWAP